Skip to main content
Log in

Effect of antiepileptic drug monotherapy on urinary pH in children and young adults

  • Original Paper
  • Published:
Child's Nervous System Aims and scope Submit manuscript

Abstract

Objects

Since alkaline urine is a risk factor for urolithiasis, the relationship between antiepileptic drugs and urinary pH was retrospectively studied in epilepsy patients treated with antiepileptic drug monotherapy for more than 1 month.

Methods

A total of 913 urinary samples from antiepileptic drug-treated patients were compared with 780 age-matched control samples, and with 112 samples from epilepsy patients who had not been treated with antiepileptic drugs. The antiepileptic drugs administered were carbamazepine, valproate, phenobarbital, zonisamide, sulthiame, and phenytoin.

Conclusions

The proportion of the acid urine in the valproate-treated patients was lower than that in controls. The proportion of the alkaline urine in the valproate-treated patients was higher than that in controls. This effect was independent of age, sex, and the serum valproate concentration. There was no significant difference in urinary pH among the epilepsy patients treated with other antiepileptic drugs, the epilepsy patients who had not been treated with antiepileptic drugs, and the controls.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Cepelak I, Rekic B, Juretic D, Mandusi A (1995) Effect of sodium valproate on renal cell brush-border enzymes in rats. Eur J Clin Chem Clin Biochem 33:673–677

    Google Scholar 

  2. Glauser TA (1997) Topiramate. Semin Pediatr Neurol 4:34–42

    CAS  PubMed  Google Scholar 

  3. Go T (2003) Effect of antiepileptic drug monotherapy on crystalluria in children and young adults. J Neurol 250:1251–1252

    Article  CAS  PubMed  Google Scholar 

  4. Go T (2005) Effect of antiepileptic drug polytherapy on crystalluria. Pediatr Neurol 32:113–115

    Article  PubMed  Google Scholar 

  5. Inoue T, Kira R, Kaku Y, Ikeda K, Gondo K, Hara T (2000) Renal tubular acidosis associated with zonisamide therapy. Epilepsia 41:1642–1644

    CAS  PubMed  Google Scholar 

  6. Korinthenberg R, Säger J, Zimmerhackl LB (2000) Increased urinary excretion of tubular enzymes and proteins in children with epilepsy. Eur J Paediatr Neurol 4:263–267

    Article  CAS  PubMed  Google Scholar 

  7. Kubota M, Nishi-Nagae M, Sakakihara Y, Noma S, Nakamoto M, Kawaguchi H, Yanagisawa M (2000) Zonisamide-induced urinary lithiasis in patients with intractable epilepsy. Brain Dev 22:230–233

    Article  CAS  PubMed  Google Scholar 

  8. Leppik IE, Willmore LJ, Homan RW, Fromm G, Oommen KJ, Penry JK, Sackellares JC, Smith DB, Lesser RP, Wallace JD, Trudeau JL, Lamoreaux LK, Spenser M (1993) Efficacy and safety of zonisamide: results of a multicenter study. Epilepsy Res 14:165–173

    Article  CAS  PubMed  Google Scholar 

  9. Madeja M, Wolf C, Speckmann EJ (2001) Reduction of voltage-operated sodium currents by the anticonvulsant drug sulthiame. Brain Res 900:88–94

    Article  CAS  PubMed  Google Scholar 

  10. Masuda Y, Karasawa T (1993) Inhibitory effect of zonisamide on human carbonic anhydrase in vitro. Arzneimittelforschung 43:416–418

    CAS  PubMed  Google Scholar 

  11. Masuda Y, Ishizaki M, Shimizu M (1998) Zonisamide: pharmacology and clinical efficacy in epilepsy. CNS Drug Rev 4:341–360

    CAS  Google Scholar 

  12. Nakatsuji K, Matsuno Y, Nakamura N, Fujitani B, Ito T, Kadokawa T (1987) General pharmacology of the novel antiepileptic compound zonisamide. 2nd communication: effect on cardiovascular, visceral, renal, and blood functions. Arzneimittelforschung 37:1131–1136

    CAS  PubMed  Google Scholar 

  13. Oommen KJ, Mathews S (1999) Zonisamide: a new antiepileptic drug. Clin Neuropharmacol 22:192–200

    CAS  PubMed  Google Scholar 

  14. Paisley KE, Tomson CR (1999) Calcium phosphate stones during long-term acetazolamide treatment for epilepsy. Postgrad Med 75:427–428

    CAS  Google Scholar 

  15. Sparagana SP, Strand WR, Adams RC (2001) Felbamate urolithiasis. Epilepsia 42:682–685

    Article  CAS  PubMed  Google Scholar 

  16. Tanaka H, Onodera N, Ito R, Monma N, Waga S, Yokoyama M (1999) Distal type of renal tubular acidosis after anti-epileptic therapy in a girl with infantile spasms. Clin Exp Nephrol 3:311–313

    Article  Google Scholar 

  17. Tanimukai H, Inui M, Hariguchi S, Kaneko Z (1965) Antiepileptic property of inhibitors of carbonic anhydrase. Biochem Pharmacol 14:961–970

    Article  CAS  PubMed  Google Scholar 

  18. Verrotti A, Greco R, Pasacarella R, Matera V, Morgese G, Chiarelli F (2000) Renal tubular function in patients receiving anticonvulsant therapy: a long-term study. Epilepsia 41:1432–1435

    CAS  PubMed  Google Scholar 

  19. Wirth N, Hoffmeister F, Sommer S (1961) The pharmacology of Ospolot. Ger Med Mon 6:309–312

    Google Scholar 

  20. Yüksel A, Cengiz M, Seven M, Cengiz S, Cenani A (1999) N-acetyl-β-glucosaminidase and β-galactosidase activity in children receiving antiepileptic drugs. Pediatr Neurol 20:24–26

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tohshin Go.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Go, T. Effect of antiepileptic drug monotherapy on urinary pH in children and young adults. Childs Nerv Syst 22, 56–59 (2006). https://doi.org/10.1007/s00381-004-1130-0

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00381-004-1130-0

Keywords

Navigation